Impact of the CYP3A5*1 Allele on the Pharmacokinetics of Tacrolimus in Japanese Heart Transplant Patients

被引：0
|
作者：
Takaya Uno
Kyoichi Wada
Sachi Matsuda
Yuka Terada
Akira Oita
Atsushi Kawase
Mitsutaka Takada
机构：
[1] National Cerebral and Cardiovascular Center,Department of Pharmacy
[2] Kindai University,Division of Clinical Drug Informatics, Faculty of Pharmacy
[3] Kindai University,Department of Pharmacy, Faculty of Pharmacy
[4] Kindai University Graduate School of Pharmacy,Division of Cardiovascular Drugs, Therapy
来源：
European Journal of Drug Metabolism and Pharmacokinetics | 2018年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [31] Impact of the CYP3A5*1/*3 alleles on the pharmacokinetics of two tacrolimus formulations after renal transplantation
    Bartling, P.
    Wehland, M.
    Brakemeier, S.
    Bauer, S.
    Glander, P.
    Slowinski, T.
    Neumayer, H. H.
    Budde, K.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 508 - 508
  • [32] Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients
    Shao, Jia
    Wang, Chenyu
    Fu, Peng
    Chen, Fan
    Zhang, Yi
    Wei, Jinxia
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (07) : 652 - 661
  • [33] The effect of sex on the pharmacokinetics of tacrolimus in SLE or RA patients with CYP3A5*3/*3
    Hashita, T.
    Ito, A.
    Okada, Y.
    Aomori, T.
    Araki, T.
    Hiromura, K.
    Nojima, Y.
    Nakamura, T.
    Yamamoto, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 883 - 883
  • [34] Association between the CYP3A5*1 Allele, Tacrolimus Concentrations and Renal Function in Lung Transplant Recipients.
    Schoeppler, K.
    Kiser, T.
    Aquilante, C.
    Fish, D.
    Zamora, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 302 - 302
  • [35] CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients
    Shigeru Satoh
    Mitsuru Saito
    Takamitsu Inoue
    Hideaki Kagaya
    Masatomo Miura
    Kazuyuki Inoue
    Atsushi Komatsuda
    Norihiko Tsuchiya
    Toshio Suzuki
    Tomonori Habuchi
    European Journal of Clinical Pharmacology, 2009, 65
  • [36] CYP3A5*1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients
    Satoh, Shigeru
    Saito, Mitsuru
    Inoue, Takamitsu
    Kagaya, Hideaki
    Miura, Masatomo
    Inoue, Kazuyuki
    Komatsuda, Atsushi
    Tsuchiya, Norihiko
    Suzuki, Toshio
    Habuchi, Tomonori
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (05) : 473 - 481
  • [37] IMPACT OF DONOR AND RECIPIENT CYP3A5, CYP3A4 AND ABCB1 POLYMORPHISMS ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME IN LIVER TRANSPLANT RECIPIENTS
    Falconer, Stuart
    Cryer, Claire
    Turner, David
    Oniscu, Gabriel
    TRANSPLANT INTERNATIONAL, 2013, 26 : 91 - 91
  • [38] Association of Hemoglobin Levels, CYP3A5, and NR1I3 Gene Polymorphisms with Tacrolimus Pharmacokinetics in Liver Transplant Patients
    Chen, Dawei
    Guo, Feng
    Shi, Jinxiu
    Zhang, Chenhui
    Wang, Zhaowen
    Fan, Junwei
    Peng, Zhihai
    DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (03) : 249 - 253
  • [39] Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
    Li, D.
    Lu, W.
    Zhu, J.-Y.
    Gao, J.
    Lou, Y.-Q.
    Zhang, G.-L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 505 - 515
  • [40] POLIMORPHISMS IN THE CYP3A4, CYP3A5 AND ABCB1 GENES MODIFY TACROLIMUS PHARMACOKINETICS AND PHARMACODYNAMICS IN RENAL TRANSPLANT
    Garcia, M.
    Macias, R. M.
    Caravaca, F.
    Benitez, J.
    Cubero, J.
    Carrillo, J. A.
    Gervasini, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 64 - 64
12345